Adalimumab is a fully human monoclonal IgG1 antibody that selectively neutralizes human TNF-alpha. It is widely used in research models of rheumatoid arthritis, ankylosing spondylitis, and psoriasis, facilitating both in vitro mechanistic studies and in vivo preclinical investigations.
Konzentration:
54.5 mg/mL
Molekulargewicht:
145.4 kDa
Reinheit:
99.50% (May vary between batches)
CAS Nummer:
[331731-18-1]
Target-Kategorie:
Antibacterial,TNF
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten